Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

NCT00460421

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Loma Linda University Loma Linda, California, United States
  • Children´s Hospital Los Angeles, California, United States
  • Regents of University of California Los Angeles, California, United States
View Trial Details
Completed

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

NCT00666484

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • University College Hospital - London London, England, United Kingdom
  • King's College Hospital London, England, United Kingdom
  • Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle upon Tyne, England, United Kingdom
View Trial Details
Completed

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

NCT00971763

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Sussex Cancer Centre at Royal Sussex County Hospital Brighton, England, United Kingdom
  • Leeds General Infirmary Leeds, England, United Kingdom
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Cancer Research UK and University College London Cancer Trials Centre London, England, United Kingdom
View Trial Details
Completed

Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma

NCT00660231

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Saint Bartholomew's Hospital London, England, United Kingdom
  • St. Thomas' Hospital London, England, United Kingdom
  • Christie Hospital Manchester, England, United Kingdom
View Trial Details
Completed

AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia

NCT01431664

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Royal Marsden Hospital Surrey, London, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Leeds General Infirmary Leeds, United Kingdom
  • Royal Manchester Children's Hospital Manchester, United Kingdom
View Trial Details
Completed

A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment

NCT01561911

Conditions
B-Cell, Cancer, Hemic and Lymphatic Diseases, +8 more
Locations
  • Cancer Research UK Institute for Cancer Studies, University of Birmingham Edgbaston, Birmingham, United Kingdom
  • Cancer Research UK Medical Oncology Unit, Southampton General Hospital Tremona Road,, Southampton, United Kingdom
View Trial Details
Completed

IMGN901 in Combination With Lenalidomide and Dexamethasone

NCT00991562

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Comprehensive Cancer Center of the Desert Palm Springs, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details

Related conditions